CONGENITAL HYPERINSULINISM INTERNATIONAL
Mission Statement
CHI is a leading nonprofit dedicated to improving the lives of children and adults living with Congenital Hyperinsulinism (HI). CHI provides a world of information, resources, and support to the HI community. CHI advocates on behalf of patients for better treatments and access to care. CHI is dedicated to increasing awareness of the disorder as it leads to more timely diagnosis and the best outcomes for patients. CHI supports medical research for improved therapies, potential cures, and timely diagnosis. CHI works globally because we are stronger as an international community. Cooperation across borders fosters important advances in medicine. HI is a life-threatening disorder that causes dangerously low blood sugar levels. Prolonged or severe low blood sugar can cause seizures, brain damage, and even death. We hope you will partner with us to prevent damage and death, search for better treatments, and improve the quality of life for all HI patients.
Financial Overview — FY 2024
Compared with Peers
FY 2024| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
88.1% | 82.3% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
5.3% | 11.5% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
6.6% | 2.8% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
276.8% | 110.9% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
19.7 mo | 11.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
14.7% | 12.7% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
76.7% | 91.5% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
10.9% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
8.0% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
11.7% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.3M | $1.1M | $1.9M | 88.1% | 9 |
| 2023 | $1.2M | $1.0M | $1.7M | 88.2% | 8 |
| 2022 | $1.3M | $834K | $1.6M | 84.4% | 5 |
| 2021 | $888K | $542K | N/A | — | 5 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.